A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation

BACKGROUND: Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Cannabidiol (CBD) has been shown to have anxiolytic and antipsychotic effects with high doses administered orally. We report a series of studies conducted to determine the vaporisation...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Pharmacol Toxicol
Prif Awduron: Solowij, Nadia, Broyd, Samantha J, van Hell, Hendrika H, Hazekamp, Arno
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2014
Pynciau:
Technical Advance
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
https://ncbi.nlm.nih.gov/pubmed/25319497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-15-58
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg